Company intelligence / Profile preview
Calando Pharmaceuticals
Pasadena, California, United Statescalandopharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Completed Phase 1 clinical trials for IT-101 in 2009 and initiated Phase 1 trial for CALAA-01 in 2008, which was the first clinical study using targeted, systemic delivery of siRNA in oncology. The company appears to be out of business as of the search results.
- Therapeutic areas
- Oncology
- Modalities
- siRNA therapeuticsNanoparticle drug formulations
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Cerulean Pharma Inc.
Beyond the preview
Go deeper on Calando Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Calando Pharmaceuticals.